Kidney Transplantation Abroad
Kidney transplantation abroad should be planned as a staged medical and legal pathway. It is not enough to know that the recipient has kidney failure and the donor is willing. The transplant team must confirm that the recipient has a valid indication, that transplantation is medically safer or more beneficial than remaining on dialysis, that the donor is healthy enough to donate, that the donor-recipient relationship is lawful and documented, and that both people understand the risks, responsibilities, and follow-up requirements.
For international patients, the most practical route is living donor kidney transplantation. The recipient may be on hemodialysis, peritoneal dialysis, or approaching dialysis with advanced chronic kidney disease. The timing changes planning. A patient already on dialysis may need dialysis coordination before and during travel, while a pre-dialysis patient may need careful timing to avoid unnecessary delay without rushing into incomplete evaluation.
Initial Medical Information
The first questions should be collected before a meaningful medical opinion is given: Is the patient on dialysis? If yes, since when, which type, and how many sessions per week? What is the transplant indication or primary kidney diagnosis? What are the recipient age, height, weight, blood group, comorbidities, previous operations, and current medications? What are the donor age, height, weight, blood group, medical history, and relationship to the recipient? Without these details, the case cannot be safely filtered.
Recipient Evaluation
The recipient assessment must identify both the reason for kidney failure and the risks that may affect surgery, immunosuppression, and long-term graft survival. Chronic kidney disease caused by diabetes, hypertension, polycystic kidney disease, reflux nephropathy, glomerulonephritis, autoimmune disease, congenital disease, or unknown causes may require different review. Some conditions can recur after transplantation; others raise specific infection, cardiovascular, or malignancy concerns.
Important recipient records include nephrology reports, dialysis records, latest laboratory tests, blood group, creatinine and eGFR trend, urine output if present, proteinuria, imaging of kidneys and urinary tract, vascular access history, cardiac evaluation, infection screening, vaccination status, malignancy screening, previous transfusions, previous transplant history, pregnancy history in female patients, and current medications. The team must also understand social support, ability to take medication reliably, and access to follow-up after return home.
Cardiovascular Assessment
Cardiovascular assessment is particularly important in kidney failure. Many recipients have hypertension, diabetes, vascular disease, left ventricular hypertrophy, coronary artery disease, or reduced exercise tolerance. ECG, echocardiography, stress testing, coronary imaging, or cardiology review may be required depending on age, risk factors, symptoms, and local protocol. A technically possible kidney transplant should not proceed if the cardiac risk is unacceptable or unassessed.
Infection and Cancer Screening
Infection and cancer screening also matter because immunosuppression after transplant can worsen active infection or alter cancer risk. Hepatitis B, hepatitis C, HIV, CMV, EBV, tuberculosis risk, urinary infection, dental infection, chronic wounds, and other sources of infection may need investigation or treatment. A history of malignancy does not always prevent transplantation, but remission duration, cancer type, recurrence risk, and oncology documentation can change the recommendation.
Donor Evaluation and Donor Protection
The living kidney donor is not a patient receiving treatment; the donor is a healthy person accepting risk for the benefit of another person. Donor protection is therefore central. The donor must be medically fit, psychologically competent, informed, free from coercion, and able to withdraw at any point before surgery without pressure or blame. The evaluation should be independent enough to protect the donor’s interests, not only the recipient’s need.
Donor assessment usually includes blood group, kidney function, urinalysis, proteinuria, blood pressure assessment, diabetes screening, cardiovascular review, infection screening, malignancy screening, body mass index, medication review, family history of kidney disease, pregnancy considerations when relevant, and imaging of kidney anatomy. CT angiography or similar vascular imaging may be used to evaluate renal arteries, veins, collecting system, stones, cysts, or anatomical variations.
The donor’s future matters. A donor with diabetes, uncontrolled hypertension, significant kidney function reduction, persistent proteinuria, active infection, certain malignancy histories, severe psychiatric instability, or unacceptable surgical risk may not be suitable. In inherited kidney diseases, related donors may need extra evaluation because the donor may share the same genetic risk as the recipient. Polycystic kidney disease, Alport syndrome, or familial glomerular diseases must be considered carefully.
After donation, the donor should not disappear from care. Kidney donor follow-up includes early surgical recovery and long-term checks such as blood pressure, body mass index, kidney function, fasting glucose, and proteinuria. The Turkish Ministry clinical protocol for living kidney donor selection and lifelong follow-up emphasizes that donor assessment and post-donation monitoring are part of the same pathway.
Immunology, Blood Group, Crossmatch, and Complex Preparation
Kidney transplantation depends heavily on immunologic compatibility. Blood group, HLA typing, donor-specific antibodies, panel reactive antibody status, and crossmatch results can change the plan. A patient with previous blood transfusions, pregnancy, or previous transplant may be sensitized and may have a higher risk of antibody-mediated rejection. This is why immunology cannot be replaced by a simple statement that the donor is a relative.
If blood group or crossmatch findings are unfavorable, the transplant team may discuss alternatives, further testing, desensitization, paired donation where legally and practically available, or refusal of the case. Complex immunologic cases may require plasmapheresis, IVIG, rituximab, ATG, or other specialized protocols in selected situations. These are not routine for every patient and can significantly affect cost, timing, infection risk, hospital stay, and follow-up intensity.
Evaluation Timeline and Staged Planning
A practical staged planning model may involve a first evaluation period of approximately five days for donor and recipient testing, document review, specialist consultations, and initial transplant board planning. Based on those results, the second visit or definitive transplant period can be arranged. In more complex immunologic preparation, the patient may require a longer protocol with treatment days, breaks, repeat testing, and final surgery timing. The example of a minimum seventeen-day second period should be understood as a planning model, not a universal guarantee; real timing depends on test results, ethics approval, dialysis needs, infection status, and hospital protocol.
Ethics Committee and Required Documents
Before living donor kidney transplantation, the documentation pathway must be treated with the same seriousness as medical testing. For international patients, documents often need to prove identity, family relationship, civil registration, marital status when relevant, donor consent, absence of commercial relationship, donor capacity, and the social or financial background necessary for ethics committee review. If the documents are issued outside Turkey, apostille and certified translation may be required according to the issuing country and hospital process.
Typical document themes include passport or identity copies for recipient and donor, apostilled civil registration records, official proof of relationship up to the accepted degree of kinship, notarized copies when requested, donor psychiatric capacity or competence report, donor consent with witnesses, detailed informed consent, health board reports, income declaration, social security or equivalent documentation, residence records, criminal record documents, tax or debt-related documents, spouse consent if the donor is married, witness identity information, and any additional documents requested by the committee.
These documents are not only for bureaucracy. They help the ethics committee evaluate whether the donor is acting freely, whether the relationship is genuine, whether there is any sign of payment or exploitation, and whether the transplant should proceed. If documents are incomplete, inconsistent, or suspicious, the medical plan may be delayed or refused. Families should be warned early that original documents may need to be submitted several days before the committee date.
References
- Republic of Türkiye Ministry of Health. Organ and Tissue Transplantation Services Regulation.
- Republic of Türkiye Ministry of Health. Law No. 2238 on the Removal, Preservation, Grafting and Transplantation of Organs and Tissues.
- Republic of Türkiye Ministry of Health. Living Kidney Donor Selection and Lifelong Follow-Up Clinical Protocol. Ankara, 2022.
- Republic of Türkiye Ministry of Health. Department of Organ Transplantation and Dialysis Services. Kidney Transplantation Standards and Official Resources.
- Kidney Disease: Improving Global Outcomes (KDIGO). Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.
- Kidney Disease: Improving Global Outcomes (KDIGO). Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.
- Declaration of Istanbul Custodian Group. The Declaration of Istanbul on Organ Trafficking and Transplant Tourism (2018 Edition).
- World Health Organization. Guiding Principles on Human Cell, Tissue and Organ Transplantation.
- The Transplantation Society. Clinical Guidance and Best Practices for Living Donor Kidney Transplantation.
- DICOM Standards Committee. Digital Imaging and Communications in Medicine (DICOM) Standard.
